Maze Therapeutics | BiotechTV

top of page

Maze Therapeutics, which had its IPO earlier this year, is using insights from genetics to develop small molecules - its most advanced program is for a genetic kidney disease

CEO Jason Coloma walks us through the science that is taking place at the company's South San Francisco headquarters, and descrbies the...

Company News

Aug 11

The CEO of Maze Therapeutics' shares his perspective on FTC's scuttling of his company's licensing deal with Sanofi

Jason Coloma shares the smaller company's perspective of how a licensing deal was scuttled by the FTC.

Company News

Jan 8, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page

Maze Therapeutics, which had its IPO earlier this year, is using insights from genetics to develop small molecules - its most advanced program is for a genetic kidney disease

The CEO of Maze Therapeutics' shares his perspective on FTC's scuttling of his company's licensing deal with Sanofi

Follow BiotechTV

Sponsors

Sponsor Spotlight